Thirty subjects with early PD ( Hoehn & Yahr Stage II off medication ) were randomized to optimal drug therapy ( ODT ) ( n = 15 ) or bilateral subthalamic nucleus ( STN ) DBS+ODT ( n = 15 ) after completing an expanded informed consent process specially designed for the study and administered by a medical ethicist and the study team .